The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
October 17th 2024
Compared with brentuximab vedotin and chemotherapy, nivolumab and chemotherapy had longer progression-free survival and a better safety profile.
Novel Formulation of Bortezomib for Multiple Myeloma May Improve Efficacy and Reduce Adverse Events
July 9th 2014Researchers at the Dana-Farber Cancer Institute and Brigham and Women's Hospital have tested a nanomedicine technology in mice formulated to precisely target myeloma cancer cells with a novel bortezomib delivery system.
Read More
In Breast Cancer, a Blood Test Could Determine the Next Stage of Therapy
June 25th 2014Researchers in the United Kingdom have identified a blood test for circulating free DNA that may help physicians predict whether or not a patient with breast cancer is likely to respond to an initial round of chemotherapy, enabling earlier initiation of alternate treatments.
Read More
AUA Guideline Presentation: Castration Resistant Prostate Cancer
June 17th 2014This presentation by Michael S. Cookson, MD, MMHC, vice chairman and Hart Professor of Urologic Surgery at Vanderbilt University Medical Center, addresses prostate cancer treatment options for 6 common clinical scenarios.
Watch
Charles M. Perou, PhD, Discusses Genomic Signatures and Dual HER2-Targeting in Breast Cancer
June 17th 2014Charles M. Perou, PhD, professor of genetics, pathology & laboratory medicine, UNC Lineberger Comprehensive Cancer Center, discusses a trial (CALGB 40601) presented at the 2014 ASCO Annual Meeting.
Watch